People: AcelRx Pharmaceuticals Inc (ACRX.O)
22 May 2017
Mr. Lawrence G. Hamel is the Chief Development Officer of AcelRx Pharmaceuticals Inc., since September 2006. From 1986 until September 2006, Mr. Hamel served as Product Development Manager, Director Project Management, Executive Director Oral Product Development, and Vice President Oral Products Development at ALZA Corporation. From 1977 until 1985, Mr. Hamel held a number of other positions at ALZA Corporation, including Senior Chemist, Research Scientist, and Senior Research Fellow. Mr. Hamel holds a B.S. in Biology from the University of Michigan.
|Total Annual Compensation, USD||1,069,670|
|Restricted Stock Awards, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||7,800|
|Fiscal Year Total, USD||1,077,470|